Table 1 Comparison of Baseline Characteristics between Non-MAFLD and MAFLD Groups.
From: The association of TyG-BMI with MAFLD and liver fibrosis: a cross-sectional study
Non-MAFLD Group (n = 782) | MAFLD Group (n = 675) | P-value | |
|---|---|---|---|
Age (years) | 49.93 ± 12.00 | 52.20 ± 11.79 | < 0.001 |
Male, n (%) | 172(21.97%) | 178(26.37%) | 0.05 |
Smoking, n (% | 45(5.75%) | 69(10.22%) | < 0.001 |
Hypertension, n (%) | 76(9.71%) | 124(18.37%) | < 0.001 |
Diabetes, n (%) | 51(6.52%) | 141(20.89%) | < 0.001 |
Height (cm) | 164.37 ± 7.71 | 164.92 ± 8.26 | 0.620 |
Weight (kg) | 64.16 ± 11.06 | 74.01 ± 13.21 | < 0.001 |
BMI (kg/m²) | 23.69 ± 3.36 | 27.12 ± 3.80 | < 0.001 |
FPG (mmol/L) | 5.24 ± 1.26 | 5.91 ± 1.79 | < 0.001 |
HbA1c (%) | 5.73 ± 0.77 | 6.13 ± 1.12 | < 0.001 |
TG (mmol/L) | 1.16 ± 0.68 | 2.02 ± 2.36 | < 0.001 |
TC (mmol/L) | 5.31 ± 1.03 | 5.49 ± 1.17 | 0.002 |
HDL-C (mmol/L) | 1.53 ± 0.35 | 1.29 ± 0.31 | < 0.001 |
LDL-C (mmol/L) | 3.23 ± 0.85 | 3.50 ± 0.91 | < 0.001 |
ALT (U/L) | 18.86 ± 15.68 | 27.31 ± 22.85 | < 0.001 |
AST (U/L) | 22.23 ± 12.53 | 24.08 ± 11.20 | < 0.001 |
ALB (g/L) | 45.25 ± 2.09 | 45.32 ± 2.04 | 0.563 |
GGT (U/L) | 23.93 ± 16.78 | 34.72 ± 24.88 | < 0.001 |
PLT (×10^9/L) | 250.95 ± 59.31 | 262.20 ± 61.69 | < 0.001 |
LSM (kPa) | 4.61 ± 1.73 | 5.28 ± 1.84 | < 0.001 |
CAP ( dB/m) | 208.42 ± 25.50 | 296.51 ± 36.46 | < 0.001 |
TyG-BMI | 198.44 ± 33.99 | 242.02 ± 41.04 | < 0.001 |
FLI | 20.33 ± 18.65 | 47.07 ± 25.92 | < 0.001 |
